September 1, 2009 By:Lakshmi Subbarao, Jacquelyn Cole, Rui Chen, TharSFC, a Waters Company
Regulatory requirements for the identification, quantification, and control of impurities in drug substances and their formulated products are increasingly being explicitly defined, particularly through the International Conference of Harmonization (ICH).
 |
September 1, 2009 By:Ray Sanchez, Penggao Duan, Darwin Asa, Bruker Daltonics Inc.
In the pharmaceutical industry the increased efficiency brought about by new fast chromatography methods needs to be matched by commensurate mass spec capabilities. maXis UHR-TOF is the instrument of choice to keep up with fastest chromatography.
 |
September 1, 2009 By:Elli Abbasi, Jeff Layne, Heiko Behr, Sky Countryman, Phenomenex, Inc.
Recently a newly developed Kinetex 2.6 µm Core-Shell chromatographic particle has been commercialized that offers the performance benefits of sub-2 µm fully-porous particles but at substantially lower operating pressures.
 |
September 1, 2009 By:Biotage AB
Traditional liquid-liquid extraction (LLE) can provide very clean extract. However, in many cases lower recoveries, labor-intensive liquid handling issues, and difficulty with automation can limit the success of LLE in sample preparation.
 |
September 1, 2009 By:Hamilton Company
Hamilton Company is best known for manufacturing precision fluid measuring products, including syringes for HPLC and GC.
 |
July 2, 2009 By:Xiaodong Liu, Christopher Pohl
Salt formation is a critical aspect in drug development and HPLC is an important tool for determination of pharmaceutical counterions.
 |
|